Статті в журналах з теми "Tasimelteon"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Tasimelteon".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Johnsa, Jessica D., and Michael W. Neville. "Tasimelteon." Annals of Pharmacotherapy 48, no. 12 (September 9, 2014): 1636–41. http://dx.doi.org/10.1177/1060028014550476.
Повний текст джерелаBonacci, Janene M., Jineane V. Venci, and Mona A. Gandhi. "Tasimelteon (Hetlioz™)." Journal of Pharmacy Practice 28, no. 5 (August 3, 2014): 473–78. http://dx.doi.org/10.1177/0897190014544792.
Повний текст джерелаBrooks, J., M. Gibson, K. Kite, E. Czeisler, M. Fisher, C. Xiao, C. Polymeropoulos, and M. Polymeropoulos. "1161 Tasimelteon Shows Persistence Of Efficacy In Improving Sleep Disturbances In Patients With Smith-Magenis Syndrome (SMS) In Open-Label Extension Study." Sleep 43, Supplement_1 (April 2020): A442—A444. http://dx.doi.org/10.1093/sleep/zsaa056.1155.
Повний текст джерелаLankford, D. Alan. "Tasimelteon for insomnia." Expert Opinion on Investigational Drugs 20, no. 7 (May 9, 2011): 987–93. http://dx.doi.org/10.1517/13543784.2011.583235.
Повний текст джерела&NA;. "Tasimelteon tackles chronic insomnia." Inpharma Weekly &NA;, no. 1645 (July 2008): 5. http://dx.doi.org/10.2165/00128413-200816450-00013.
Повний текст джерелаTorres, Rosarelis, Marlene A. Dressman, William G. Kramer, and Paolo Baroldi. "Absolute Bioavailability of Tasimelteon." American Journal of Therapeutics 22, no. 5 (2015): 355–60. http://dx.doi.org/10.1097/mjt.0000000000000195.
Повний текст джерелаLi, Xi-An, Lirong Yue, Jianrong Zhu, Huazhong Ren, Hong Zhang, Dong-yan Hu, Guangtian Han, Jiafu Feng, and Ze-dong Nan. "Total synthesis of Tasimelteon." Tetrahedron Letters 60, no. 30 (July 2019): 1986–88. http://dx.doi.org/10.1016/j.tetlet.2019.06.048.
Повний текст джерелаDhillon, Sohita, and Madeleine Clarke. "Tasimelteon: First Global Approval." Drugs 74, no. 4 (March 2014): 505–11. http://dx.doi.org/10.1007/s40265-014-0200-1.
Повний текст джерела&NA;. "Tasimelteon helps transient insomniacs nod off." Inpharma Weekly &NA;, no. 1667 (December 2008): 11. http://dx.doi.org/10.2165/00128413-200816670-00033.
Повний текст джерелаAdams, Katie S., and Ericka L. Breden Crouse. "Melatonin agonists in the management of sleep disorders: A focus on ramelteon and tasimelteon." Mental Health Clinician 4, no. 2 (March 1, 2014): 59–64. http://dx.doi.org/10.9740/mhc.n190087.
Повний текст джерелаMi, Senyang, Xinzhe Sun, Chaogang Wu, and Xingxian Zhang. "A Facile and Practical Synthesis of (-)-tasimelteon." Journal of Chemical Research 40, no. 11 (November 2016): 667–69. http://dx.doi.org/10.3184/174751916x14758368248634.
Повний текст джерелаStahl, Stephen M. "Mechanism of action of tasimelteon in non-24 sleep-wake syndrome: treatment for a circadian rhythm disorder in blind patients." CNS Spectrums 19, no. 6 (November 25, 2014): 475–78. http://dx.doi.org/10.1017/s1092852914000637.
Повний текст джерелаTraynor, Kate. "Tasimelteon approved for circadian disorder in blind adults." American Journal of Health-System Pharmacy 71, no. 5 (March 1, 2014): 350. http://dx.doi.org/10.2146/news140017.
Повний текст джерелаLavedan, Christian, Mark Forsberg, and Anthony J. Gentile. "Tasimelteon: A selective and unique receptor binding profile." Neuropharmacology 91 (April 2015): 142–47. http://dx.doi.org/10.1016/j.neuropharm.2014.12.004.
Повний текст джерелаWang, Wenbing, Xiangwei Meng, Jianrong Zhu, and Xingxian Zhang. "An efficient and practical asymmetric synthesis of (−)-tasimelteon." Synthetic Communications 49, no. 1 (January 2, 2019): 129–35. http://dx.doi.org/10.1080/00397911.2018.1545031.
Повний текст джерелаYuhas, Phillip T. "Non-24-Hour Sleep–Wake Disorder and Tasimelteon: A Review for Practitioners Who Work With Blind People." Journal of Visual Impairment & Blindness 116, no. 1 (January 2022): 70–84. http://dx.doi.org/10.1177/0145482x211072521.
Повний текст джерелаPolymeropoulos, C., E. Czeisler, M. Fisher, G. Birznieks, C. Xiao, V. Polymeropoulos, and M. Polymeropoulos. "Tasimelteon effective in treating JET lag during transatlantic travel." Sleep Medicine 64 (December 2019): S305. http://dx.doi.org/10.1016/j.sleep.2019.11.854.
Повний текст джерелаLiu, Kaihang, Xinbo Zhou, Zhejing Xu, Hongzhen Bai, Jianrong Zhu, Jianming Gu, Guping Tang, Xingang Liu, and Xiurong Hu. "Anhydrates and hemihydrate of tasimelteon: Synthesis, structure, and pharmacokinetic study." Journal of Pharmaceutical and Biomedical Analysis 151 (March 2018): 235–43. http://dx.doi.org/10.1016/j.jpba.2017.12.035.
Повний текст джерелаPolymeropoulos, Christos, Emily Czeisler, Michaela Fisher, Gunther Birznieks, Vasilios Polymeropoulos, Changfu Xiao, and Mihael Polymeropoulos. "0639 Tasimelteon Effective in Treating Jet Lag during Transatlantic Travel." Sleep 42, Supplement_1 (April 2019): A254—A255. http://dx.doi.org/10.1093/sleep/zsz067.637.
Повний текст джерелаNishimon, Shohei, Mari Nishimon, and Seiji Nishino. "Tasimelteon for treating non-24-h sleep-wake rhythm disorder." Expert Opinion on Pharmacotherapy 20, no. 9 (April 16, 2019): 1065–73. http://dx.doi.org/10.1080/14656566.2019.1603293.
Повний текст джерелаNeubauer, D. N. "Tasimelteon for the treatment of non-24-hour sleep-wake disorder." Drugs of Today 51, no. 1 (2015): 29. http://dx.doi.org/10.1358/dot.2015.51.1.2258364.
Повний текст джерелаPolymeropoulos, M. H., C. Xiao, and C. Polymeropoulos. "Tasimelteon improves symptoms of major depression in an African American population." Sleep Medicine 40 (December 2017): e266. http://dx.doi.org/10.1016/j.sleep.2017.11.779.
Повний текст джерелаPetrini, Agnese, Giovanni Ievoli, Francesca Migliorini, Maurizio Taddei, and Sofia Siciliano. "A Self-Immolative Linker for the pH-Responsive Release of Amides." Molecules 28, no. 6 (March 7, 2023): 2445. http://dx.doi.org/10.3390/molecules28062445.
Повний текст джерелаPolymeropoulos, M., C. Xiao, and C. Polymeropoulos. "0986 Tasimelteon Improves Symptoms of Major Depression in an African American Population." Sleep 41, suppl_1 (April 2018): A365—A366. http://dx.doi.org/10.1093/sleep/zsy061.985.
Повний текст джерелаde Klaver, P. A. G. "Melatonine agonist tasimelteon (VEC-162) bij voorbijgaande insomnia na nachtdienst: 2 gerandomiseerde onderzoeken." Medisch-Farmaceutische Mededelingen 47, no. 6 (June 2009): 93–94. http://dx.doi.org/10.1007/bf03079969.
Повний текст джерелаPolymeropoulos, C., E. Czeisler, M. Fisher, G. Birznieks, V. Polymeropoulos, C. Xiao, and M. Polymeropoulos. "Tasimelteon demonstrates efficacy in improving sleep disturbances of individuals with smith-magenis syndrome (SMS)." Sleep Medicine 64 (December 2019): S423. http://dx.doi.org/10.1016/j.sleep.2019.11.1176.
Повний текст джерелаOgilvie, Brian W., Rosarelis Torres, Marlene A. Dressman, William G. Kramer, and Paolo Baroldi. "Clinical assessment of drug–drug interactions of tasimelteon, a novel dual melatonin receptor agonist." Journal of Clinical Pharmacology 55, no. 9 (May 7, 2015): 1004–11. http://dx.doi.org/10.1002/jcph.507.
Повний текст джерелаKeating, Gillian M. "Tasimelteon: A Review in Non-24-Hour Sleep-Wake Disorder in Totally Blind Individuals." CNS Drugs 30, no. 5 (March 22, 2016): 461–68. http://dx.doi.org/10.1007/s40263-016-0330-y.
Повний текст джерелаPolymeropoulos, Christos, Emily Czeisler, Michaela Fisher, Gunther Birznieks, Vasilios Polymeropoulos, Changfu Xiao, and Mihael Polymeropoulos. "0641 Tasimelteon Demonstrates Efficacy in Improving Sleep Disturbances of Individuals with Smith-Magenis Syndrome (SMS)." Sleep 42, Supplement_1 (April 2019): A255. http://dx.doi.org/10.1093/sleep/zsz067.639.
Повний текст джерелаTorres, Rosarelis, William G. Kramer, and Paolo Baroldi. "Pharmacokinetics of the dual melatonin receptor agonist tasimelteon in subjects with hepatic or renal impairment." Journal of Clinical Pharmacology 55, no. 5 (February 4, 2015): 525–33. http://dx.doi.org/10.1002/jcph.440.
Повний текст джерелаSatyanarayanan, Senthil Kumaran, Huanxing Su, Yi-Wen Lin, and Kuan-Pin Su. "Circadian Rhythm and Melatonin in the Treatment of Depression." Current Pharmaceutical Design 24, no. 22 (October 19, 2018): 2549–55. http://dx.doi.org/10.2174/1381612824666180803112304.
Повний текст джерелаErland, Lauren A. E., Christopher R. Dumigan, Jillian A. Forsyth, Liubov Frolova, Adam B. Yasunaga, Winnie Pun, Isaac T. S. Li, Michael K. Deyholos, and Susan J. Murch. "Mammalian Melatonin Agonist Pharmaceuticals Stimulate Rhomboid Proteins in Plants." Biomolecules 12, no. 7 (June 24, 2022): 882. http://dx.doi.org/10.3390/biom12070882.
Повний текст джерелаEdmonds, Chelsey, and Michael Swanoski. "A Review of Suvorexant, Doxepin, Ramelteon, and Tasimelteon for the Treatment of Insomnia in Geriatric Patients." Consultant Pharmacist 32, no. 3 (March 1, 2017): 156–60. http://dx.doi.org/10.4140/tcp.n.2017.156.
Повний текст джерелаVentimiglia, Giampiero, Sonja Bellomi, Giuseppe Barreca, Lorella Giovannelli, and Norberto Masciocchi. "Synthesis, Characterization, and Crystal Chemistry of Tasimelteon, a Melatonin Agonist, in Its Anhydrous and Hemihydrate Forms." Journal of Pharmaceutical Sciences 107, no. 2 (February 2018): 543–49. http://dx.doi.org/10.1016/j.xphs.2017.09.012.
Повний текст джерелаXiao, C., C. Polymeropoulos, J. Brzezynski, L. Prokosch, M. Keefe, M. Mohrman, G. Birznieks, and M. Polymeropoulos. "Tasimelteon demonstrates efficacy to treat jet lag disorder in an 8 hour phase advance clinical study." Sleep Medicine 64 (December 2019): S423. http://dx.doi.org/10.1016/j.sleep.2019.11.1175.
Повний текст джерелаLeger, Damien, Maria-Antonia Quera-Salva, Marie-Françoise Vecchierini, Pascale Ogrizek, Christina A. Perry, and Marlene A. Dressman. "Safety profile of tasimelteon, a melatonin MT1and MT2receptor agonist: pooled safety analyses from six clinical studies." Expert Opinion on Drug Safety 14, no. 11 (September 22, 2015): 1673–85. http://dx.doi.org/10.1517/14740338.2015.1093112.
Повний текст джерелаRajaratnam, Shantha MW, Mihael H. Polymeropoulos, Dennis M. Fisher, Thomas Roth, Christin Scott, Gunther Birznieks, and Elizabeth B. Klerman. "Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials." Lancet 373, no. 9662 (February 2009): 482–91. http://dx.doi.org/10.1016/s0140-6736(08)61812-7.
Повний текст джерелаPolymeropoulos, Vasilios, Jim Wang, Christos Polymeropoulos, Changfu Xiao, and Mihael Polymeropoulos. "0640 Tasimelteon Significantly Improves REM Sleep Accumulation During an 8-hour Phase Advance in the JET8 Study." Sleep 42, Supplement_1 (April 2019): A255. http://dx.doi.org/10.1093/sleep/zsz067.638.
Повний текст джерелаRajaratnam, Shantha M. W., Mihael H. Polymeropoulos, Dennis M. Fisher, Thomas Roth, Christin Scott, Gunther Birznieks, and Elizabeth B. Klerman. "Melatonin Agonist Tasimelteon (VEC-162) for Transient Insomnia After Sleep-Time Shift: Two Randomized Controlled Multicentre Trials." Obstetrical & Gynecological Survey 64, no. 9 (September 2009): 604–5. http://dx.doi.org/10.1097/01.ogx.0000358014.55641.1c.
Повний текст джерелаMoschona, Fotini, Ioanna Savvopoulou, Maria Tsitopoulou, Despoina Tataraki, and Gerasimos Rassias. "Epoxide Syntheses and Ring-Opening Reactions in Drug Development." Catalysts 10, no. 10 (September 27, 2020): 1117. http://dx.doi.org/10.3390/catal10101117.
Повний текст джерелаSukys-Claudino, Lucia, Walter André dos Santos Moraes, Sergio Tufik, and Dalva Poyares. "Novos sedativos hipnóticos." Revista Brasileira de Psiquiatria 32, no. 3 (September 2010): 288–93. http://dx.doi.org/10.1590/s1516-44462010000300014.
Повний текст джерелаLockley, Steven, Marlene Dressman, Xiao Changfu, Dennis Fisher, Rosarelis Torres, Christian Lavedan, Louis Licamele, and Mihael Polymeropoulos. "Le tasimelteon entraîne l’horloge circadienne et procure une amélioration significative aux personnes totalement aveugles, souffrant du libre-cours." Médecine du Sommeil 12, no. 1 (January 2015): 55–56. http://dx.doi.org/10.1016/j.msom.2015.01.099.
Повний текст джерелаHull, J. T., C. Polymeropoulos, Y. Cho, C. Xiao, and M. H. Polymeropoulos. "Tasimelteon improves sleep quality and behavior in individuals with Smith-Magenis syndrome (SMS) in an open-label study." Sleep Medicine 40 (December 2017): e139. http://dx.doi.org/10.1016/j.sleep.2017.11.406.
Повний текст джерелаPolymeropoulos, V., C. Polymeropoulos, G. Birznieks, C. Xiao, and M. Polymeropoulos. "Tasimelteon significantly improves time to 30 minutes of REM (REM30) as compared to placebo in the JET8 study." Sleep Medicine 64 (December 2019): S305. http://dx.doi.org/10.1016/j.sleep.2019.11.855.
Повний текст джерелаVan Draanen, L., C. Xiao, and M. H. Polymeropoulos. "0649 Tasimelteon Improves Number of Sleep Free Days in Blind Patients with Non-24-Hour Sleep-Wake Disorder." Sleep 41, suppl_1 (April 2018): A241. http://dx.doi.org/10.1093/sleep/zsy061.648.
Повний текст джерелаHull, J. T., C. Polymeropoulos, C. Xiao, and M. H. Polymeropoulos. "0925 Tasimelteon Improves Sleep Quality and Behavior in Individuals with Smith-Magenis Syndrome (SMS) in an Open-Label Study." Sleep 41, suppl_1 (April 2018): A343. http://dx.doi.org/10.1093/sleep/zsy061.924.
Повний текст джерелаQuera-Salva, Maria-Antonia, Marlene Dressman, Christina Perry, Marie-Françoise Vecchierini, Pascale Ogrizek, Christian Lavedan, and Damien Leger. "Étude de sécurité, multicentrique, en ouvert, du tasimelteon pour le traitement du syndrome libre-cours chez les personnes totalement aveugles." Médecine du Sommeil 12, no. 1 (January 2015): 55. http://dx.doi.org/10.1016/j.msom.2015.01.098.
Повний текст джерелаLicamele, L., C. Xiao, ER Schreffler, A. Williams, and MH Polymeropoulos. "0709 TASIMELTEON TREATMENT ACHIEVED CLINICALLY IMPORTANT DIFFERENCE IN SLEEP QUALITY IN BLIND INDIVIDUALS WITH NON-24-HOUR SLEEP-WAKE DISORDER." Sleep 40, suppl_1 (April 28, 2017): A262—A263. http://dx.doi.org/10.1093/sleepj/zsx050.708.
Повний текст джерелаDirks, Christina, Peter Young, and Anna Heidbreder. "Non-24h-Schlaf-Wach-Rhythmusstörung bei blinden Patienten." Nervenheilkunde 38, no. 03 (February 2019): 115–19. http://dx.doi.org/10.1055/a-0819-2962.
Повний текст джерелаYadlapalli, Siva Sankara Rao, Vijaya Kumari Karra, Vinutha Kommineni, Naresh Kumar Katari, and Surendra Babu Manabolu Surya. "Bioanalytical technique for determination of tasimelteon in human plasma by LC–MS/MS and its application to pharmacokinetic study in humans." Biomedical Chromatography 33, no. 3 (December 12, 2018): e4431. http://dx.doi.org/10.1002/bmc.4431.
Повний текст джерела